From Facebook...Cord Blood America Investors Forum...Concerning recent news regarding placenta revenue. As of now it is 5% of revenue. Do you see this revenue growing significantly over the short term and long term? And is there going to be a release of the companies name we are suppling with these placentas?
Also BIOCELL deal has a delay. Is there anything you can tell u...s about that?
ANS - BioCells is delayed just a few days. Simply put, there are both English and Spanish speaking attorneys and the documents have to be done in both languages. This is the reason for the delay. Nothing else. We suspect only a couple of more days. As for the placenta revenue, it depends upon the demand for it. Because the demand is research driven, we are unsure. CBAI has put ourselves in position to be a great supplier if the demand does increase. The demand comes from R&D, not families, so its tough to tell. That said, I do believe it will increase significantly over time........good luck, michael
